NuVasive's biologics portfolio includes AttraX Putty.
Here are four things to know.
1. AttraX Putty is a synthetic, resorbable, osteoconductive bone void filler intended for the repair of bony defects.
2. AttraX Putty's calcium phosphate granules have a biotextured surface structure to facilitate 3D bone regeneration in the defect site into which the putty is implanted.
3. The AttraX implant is replaced by bone during natural bone remodeling.
4. The technology received FDA clearance in October 2015 and has been used globally since 2011.
More articles on biologics:
Target stem cells to stop osteoarthritis progression, study suggests: 3 insights
Stem cell-derived neurons survive grafting into spinal cord injury in animal study: 3 things to know
FDA seeks to shut down stem cell clinics offering unapproved treatments: 5 insights